JANSSPHARMA
ActiveFrom the official registers: KBO 18 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
JANSSPHARMA has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €239,031. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 93% of 5,036 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.